Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment ; volume:76 ; number:6 ; day:29 ; month:8 ; year:2024 ; pages:1325-1332 ; date:12.2024
Pharmacological reports ; 76, Heft 6 (29.8.2024), 1325-1332, 12.2024
- Urheber
-
Kwaśny, Aleksander
Cubała, Wiesław Jerzy
Włodarczyk, Adam
Pastuszak, Krzysztof
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s43440-024-00641-1
- URN
-
urn:nbn:de:101:1-2502072100523.824051155963
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kwaśny, Aleksander
- Cubała, Wiesław Jerzy
- Włodarczyk, Adam
- Pastuszak, Krzysztof
- SpringerLink (Online service)
Ähnliche Objekte (12)
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
Personalized use of ketamine and esketamine for treatment-resistant depression
Ketamine in multiple treatment-resistant depressed inpatients: a naturalistic cohort study
Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
Ketamine and chronic treatment-resistant depression: real-world practice and after relapse
Understanding the variability in ketamine’s efficacy in managing treatment-resistant depression
Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine
The quest for optimal ketamine dosing formula in treatment-resistant major depressive disorder
Residual Depressive Symptoms in Treatment-Resistant Bipolar Depression Following Short-Term Ketamine Administration
Cerebrospinal fluid metabolomes of treatment-resistant depression subtypes and ketamine response: a pilot study
Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression
Functional changes in sleep-related arousal after ketamine administration in individuals with treatment-resistant depression
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
Personalized use of ketamine and esketamine for treatment-resistant depression
Ketamine in multiple treatment-resistant depressed inpatients: a naturalistic cohort study
Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
Ketamine and chronic treatment-resistant depression: real-world practice and after relapse
Understanding the variability in ketamine’s efficacy in managing treatment-resistant depression
Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine
The quest for optimal ketamine dosing formula in treatment-resistant major depressive disorder
Residual Depressive Symptoms in Treatment-Resistant Bipolar Depression Following Short-Term Ketamine Administration
Cerebrospinal fluid metabolomes of treatment-resistant depression subtypes and ketamine response: a pilot study
Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression
Functional changes in sleep-related arousal after ketamine administration in individuals with treatment-resistant depression
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
Personalized use of ketamine and esketamine for treatment-resistant depression
Ketamine in multiple treatment-resistant depressed inpatients: a naturalistic cohort study
Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
Ketamine and chronic treatment-resistant depression: real-world practice and after relapse
Understanding the variability in ketamine’s efficacy in managing treatment-resistant depression
Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine
The quest for optimal ketamine dosing formula in treatment-resistant major depressive disorder
Residual Depressive Symptoms in Treatment-Resistant Bipolar Depression Following Short-Term Ketamine Administration
Cerebrospinal fluid metabolomes of treatment-resistant depression subtypes and ketamine response: a pilot study
Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression